Cyclerion Therapeutics Inc

Interactive Chart

News & Analysis: Cyclerion Therapeutics Inc

George Budwell | Oct 14, 2020

A second midstage failure is hurting the biotech's stock price today.

Brian Orelli, PhD | Oct 30, 2019

A double clinical trial failure sends the biotech’s shares down.

George Budwell | Oct 14, 2020

A second midstage failure is hurting the biotech's stock price today.

Brian Orelli, PhD | Oct 30, 2019

A double clinical trial failure sends the biotech’s shares down.

Key Data Points

Primary metrics and data points about Cyclerion Therapeutics Inc.

Business Summary

Industry, sector and description for Cyclerion Therapeutics Inc.

Exchange: Nasdaq Global Select

Sector: Health Care

Industry: Biotechnology